Jonah Musa

I am a highly passionate, innovative, and efficient professional with background training as specialist in women's health, and a trained research scientist with general interest in reproductive health and a focused interest in preventive oncology. This combination of skills has over the years sharpened my understanding of the interaction of multiple healthcare, environmental, genetic, social, economic, personal, and policy factors in influencing health, disease, health care decisions and health outcomes in different settings, globally. My unique skill sets have been of immense collaborative value in team science, linking patient's lived experience, and both distal and proximal factors in modifying health, disease, and outcomes amongst population. I have played key roles in training, conceptualizing, writing, implementing and dissemination of biomedical research projects and translating such findings to improve health outcomes, particularly in resource-limited settings. I am humble, hardworking, a goal-getter, a resilient team player and leader, prioritizing on team, organizational, institutional and global success rather than personal accomplishments!

• very adaptable to changing conditions of life
• can travel to different settings
• very friendly and always at peace with people of diverse background

i. Keynote Speaker, “Adopting lessons from innovative COVID-19 vaccination approaches to scale routine immunization uptake at Primary Health Care levels”. Virtual Side event CPHIA 2023; Nov 22, 2023

ii. Keynote Speaker Award, at the 55th Annual General Meeting and Scientific Conference Society of Gynecology and Obstetrics of Nigeria (SOGON) 2021. Theme: “Status of Reproductive Health in a COVID-19 era”, titled: “Cervical Cancer in Nigeria and LMICs: It Pays to Invest in Research and Prevention” on November 25th, 2021, Makurdi, Benue State, Nigeria.

iii. Catholic Nurses Guild of Nigeria, Awardof Honor in recognition of immense contributions and service to humanity, October 22, 2021, Jos Plateau State, Nigeria.

iv. University of Jos, Vice-Chancelor’s Merit Awardfor the 94th Inaugural Lecture, titled: A Sexually Transmissible Cancer: Miracle of Cure or Prevention? 18th May 2021.

v. Emerging Global Leader Award(International Research Career Development), NIH/Fogarty International Center, titled-“Vaginal Microbiome in Cervical intraepithelial Neoplasia and Cancer”; 2019-2024

vi. Global Health Travel Award to attend the Keystone Symposia T2, “Maternal-Fetal Cross-Talk: Harmony vs Conflict” meeting being held, October 4-8, 2017, Washington DC, USA.

vii. Northwestern University Global Health Award 2011, in recognition of excellence as Northwestern AIDS International Training and Research Program Trainee. Presented at the end of the Global Health Week Gala Dinner, “Northwestern in the World”; 7th April, 2011 in Chicago, USA.

viii. International Scholar Delegate award, to participate in the 21st Conference on Retroviruses and opportunistic Infections, March 3-6, 2014, Boston, USA.

ix. Funding award to attend the sub-Saharan African Regional Grant writing and scientific peer-review workshop,held in Johannesburg, South Africa, November 18-21, 2013. Organized by NIH/NCI/ Fogarty in collaboration with South African Medical Research Council

x. Microbicides 2012 International Scholarship awardto attend the M2012 Conference 15th-18th April, 2012 at the Sydney Convention and Exhibition centre, Sydney, Australia.

xi. CROI 2012 international Scholar program Award to attend the 19th conference on retroviruses and opportunistic infections, 5-8 March, 2012 in Seattle, Washington State, USA.

xii. 2012 Anti-Corruption and Transparency Unit, Chairman’s Integrity Award, Jos University Teaching Hospital, Jos, Nigeria

xiii. International AIDS Society Scholarship award to attend the 6th IAS conference on Pathogenesis, Treatment and Prevention of HIV, 17-20 July, 2011, Rome, Italy.

Travel award (Northwestern University Global health Center, Chicago, USA) to attend and present an oral abstract at the Consortium of Universities for Global health conference 2010, September 19-21, 2010, University of Washington, Seattle, WA, USA.

xiv. Conference support (Women Deliver 2010 Scholarship Team) to attend the Women Deliver 2010 conference, June 7-9, 2010, Washington D.C., USA.

xv. Conference support (Microbicides 2010 Scholarship Team) to attend and present a poster at the Microbicides 2010 conference, May22-25, 2010, Pittsburgh, Pennsylvania, USA.

xvi. In-Country research project (Seed grant) under D43TW007995-01A1-“The role of HPV DNA testing in detecting high grades cervical lesions among HIV infected women with normal cytology in Jos, Nigeria”.

xvii. Majekodomi Young Gynecologist Awardfor best presentation at the 43rd scientific conference and annual general meeting of the Society of Gynecology and Obstetrics of Nigeria, 2009, Kano, Nigeria.

xviii. NIH/Fogarty Research fellow, under grant #D43TW007995-01A1, titled, Northwestern University AIDS Training and Research Program (PI: Robert L. Murphy, MD) for Master of Science in Clinical Investigation program at Northwestern University, Chicago, USA, Fall 2008 to Summer 2009.

xix. Travel award to attend the Microbicides 2008conference in New Delhi, India, 24th Febuary 2008 to 27 Febuary 2008 at the Hotel Ashok, New Delhi, India

xx. WHO travel/Research training awardfor research training at the reproductive and HIV research unit, University of Witwatersrand, Johannesburg, South Africa, 21st July 2007-17thAugust 2007.

xxi. Nigeria National Youth Service Corps(NYSC) State Commendation Award, Borno State, 1997.

Scientific appointments

i. Academic Editor, PLOS ONE, Appointed, June 2023

ii. Founding Editor-in-Chief, Journal of Health Sciences and Practice, official journal of the Nigeria Medical Association, Plateau State (August 2022)

iii. Collaborator, Lancet Commission, Cancer, and Health Systems 2022-2024

iv. Academic Guest Editor, PLOS One, July 2020

v. Reviewer UK/Medical Research Council for African Research Leaders Program 2020

Reviewer to Biomedical Journals

i. AIDS

ii. Cancer Epidemiology, Biomarkers & Prevention

iii. International Journal of Gynecologic Cancers

iv. JAMA Open

v. Computational and Structural Biotechnology

vi. Journal of Obstetrics and Gynecology

vii. Oncotarget

viii. PLOS One

ix. BMC Cancer

x. CMAJ Open

xi. The Lancet Regional Health Americas

xii. AIDS care

xiii. African Journal of Reproductive Health

xiv. Journal of Medical Virology

xv. Infectious Agents and Cancer

xvi. African Health Sciences

xvii. Nigerian Journal of Medicine

xviii. Archives of Gynecology and Obstetrics

xix. Current Reviews in Respiratory Medicine

xx. Indian Journal of Critical Care Medicine

xxi. Saudi Medical Journal

xxii. Journal of Epidemiology and Public Health

xxiii. Annals of African Medicine

xxiv. Annals of Nigerian Medicine

xxv. Journal of Medicine in the Tropics

xxvi. Nigerian Medical Journal

• Medical and Dental Council of Nigeria license to practice medicine and surgery in Nigeria (FM 23,076)
• Medical and Dental Council of Nigeria, Additional qualification license to practice as specialist in obstetrics and gynecology in Nigeria (AQ 5058)

https://scholar.google.com/citations?user=5wJYGm0AAAAJ&hl=en&scioq=Jonah+Musa+university+of+Jos

ACTIVE

D43TW009575, NIH/FIC/NCI  (MPI: Achenbach/Musa/Odukoya/Silas)  07/01/24-03/31/29

Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)

Role: MPI

Major goals: This Nigerian-led research-training program will build capacity in

molecular cancer epidemiology, biostatistics, and clinical investigation to train researchers to conduct population-based molecular epidemiology and diagnostics research, leading to the development of preventative and therapeutic strategies to reduce incidence and decrease mortality of HIV-associated malignancies in Nigeria.

NIH/NCI U01CA275129

Hou/Holl/Maiga, Role: Jos Site, Co-Investigator  7/1/22 – 6/30/27 (1.32 CAL)

West Africa Self-Sampling HPV Based Cervical Cancer Control Program (WA-SS-HCCP) for WLWHA.

1U54EB027049-02. (Achenbach, Murphy R and McFall, MPI) 10/01/18 – 5/31/28 0.6 CAL.

NIH/NIBIB

The Centre for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)

This renewal cooperative agreement based at Northwestern University supports the development of a pipeline of Point-of-Care Technologies promoting NIH high priority research of HIV/AIDS and emerging Infectious Diseases in sub-Saharan Africa (Notice Number: NOT-OD-15-137). The C-THAN is part of the Point-of-Care Technologies Research Network of NIBIB. The C-THAN also aims to build biomedical research and clinical capacity for local development, validation, manufacturing, marketing, and maintenance of point-of-care technologies for low- and middle-income countries.

Role: Co-Investigator

D43 CA260658, NIH/NCI Hou L, Maiga M (MPI) 07/01/2021-06/30/2026  0.6 CAL

Infection-Associated Cancer Research Training Program in Mali (NM-IAC)

Major Goals: The NM-IAC Program seeks to build an interdisciplinary, collaborative, research training program to train researchers in the conduct of population-based cancer epidemiology and molecular studies and advance the discovery of unique population-specific risk factors and biomarkers for the development of risk stratification and screening tools of individuals with underlying infections at increased risk of associated cancers, with the goal of improving detection, treatment, and outcomes.

Role: Mentor

COMPLETED

K43 TW 011416, NIH/FIC/NCI (PI: Musa) 07/01/19-06/31/24 9.0 CAL Vaginal Microbiome in Cervical   Intraepithelial Neoplasia and Cancer

This 5-year K43 grant provided   research career development support to Dr. Jonah Musa focusing on improving   cervical cancer outcomes through prevention and early detection and treatment   of precancerous conditions of the cervix. It improved theoretical,   experiential learning and research leadership skills for Dr. Musa, and   prepared him for research and career independence. Preliminary data of this   K-award helped in submission of a R21 application, though not funded but due   for resubmission in December 2024.

Role: PI

D43TW009575, NIH/FIC/NCIMurphy RL, Hou L (MPI)  04/19/19-03/31/24  0.6 CAL Northwestern/Nigeria   Research Training Program in HIV and Malignancies (NN-HAM)

This renewal research training grant aims to   creating the next generation of research scientists in Nigeria who are   focusing their careers on molecular epidemiology, biostatistics and health   informatics related to HIV-associated cancers in Nigeria.

Role: co-Investigator

NIH/FIC R21TW12092

Zheng/Silas, Role: Co-Investigator

09/01/2021 – 08/31/2023

Global Hypomethylation   Biomarkers for Cervical Cancer Screening in Women Living with HIV

U54CA221205 (Hou L, Murphy R, MPI) 07/01/17 -   06/30/22

NIH/NCI

Epigenomic Biomarkers of HIV-Associated   Cancers in Nigeria

Cancer epigenetics and infections are inextricably linked   especially in low- and middle-income countries such as Nigeria where there is   combined high burden of HIV, hepatocellular carcinoma and cervical cancer.   The study of epigenomic biomarkers in HIV-associated cancers will improve our   understanding of the role of HIV infection in cancers and offers the main   advantage of earlier diagnosis of premalignant conditions which may lead to   effective strategies for prevention, diagnosis and treatment of cancers in   this setting.

Role: Project co-lead (Cervical Cancer)

5D43TW010130-05 (Sagay) 09/09/15 - 07/31/20

Support of Training and Mentoring in Nigeria for Academics (STAMINA)

This training grant has completed its official 5 years activities and was granted a No-Cost-Extension (NCE) till July 31, 2021. I do not have any effort during the NCE under this grant and have adjusted my effort level as such. The training program has contributed to developing research capacity and mentoring of junior faculty for locally relevant research in Jos and Ahmadu Bello University, Nigeria. The research training and mentoring focused on HIV outcomes, reproductive health, genomics and non-communicable diseases.

Role: Co-Investigator